Harvest Global Investments
VC Fund
Central, Hong Kong
Harvest Global Investments is a VC fund in Central focused on Biotechnology and Medical. Harvest Global Investments Limited (“HGI”) was established in Hong Kong as a wholly owned subsidiary of Harvest Fund Management.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Harvest Global Investments invests in
Stages Harvest Global Investments invests in
Countries Harvest Global Investments invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
|
|
|||
|
|
|||
|
Sirinda Flik
|
|||
|
Yuki Nishio
|
Investment Focus
Industry
- Biotechnology 3 (30%)
- Medical 2 (20%)
- Information Technology 2 (20%)
- B2B 1 (10%)
- B2C 1 (10%)
Stage
- Series B 3 (30%)
- Series C 2 (20%)
- Seed 1 (10%)
- Series A 1 (10%)
- Series D 1 (10%)
Country
- China 9 (90%)
- Hong Kong 1 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Angela Wang
Vice President, Business Development
|
Vice President, Business Development | Total investments: 0 | Find email | |
|
Joyce Lui
Vice President for Marketing and Business Development
|
Vice President for Marketing and Business Development | Total investments: 0 | Find email | |
|
Ruiqi Wang
Executive Director
|
Executive Director | Total investments: 0 | Find email | |
|
Sirinda Flik
Regional Business Development Manager
|
Regional Business Development Manager | Total investments: 0 | Find email | |
|
Yuki Nishio
Vice President
|
Vice President | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
iClick Interactive Asia Group Limited (NASDAQ: ICLK) is China’s largest independent online marketing technology platform that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, its proprietary platform possesses omni-channel marketing capabilities and fulfills various marketing objectives in a data-driven andautomated manner, helping both international and domestic marketers reach their target audiences in China through data-driven targeted marketing. | $25.5M / Post-IPO Equity / Jun 29, 2025 | |
|
|
Xingji Meizu Group is a platform for full-stack smart terminal technologies that spans multiple industries. The Group is actively developing cutting-edge technologies in fields such as smart EVs, smartphones, XR, in-house OS, smart wearables, smart homes, trendy lifestyles, and so on. | $276.2M / Series A / Nov 16, 2023 | |
|
|
Xingyun Group has reconstructed the digital supply chain in consumer goods. It empowers the global commodity trade environment through whole-process SaaS tools, and provides one-stop, full-category, Direct-to-consumer (DTC) digital supply chain services in consumer goods. The Management Middle-end System Services Engine of Xingyun Global SupplyChain focuses on the integration of industrial ecological resources, enables cost reduction and efficiency improvement with industrial data, serves overseas consumer brands to enter China, helps Chinese brands go global, and empowers global supply chain and SaaS service capability of the platform for massive merchants. It has nearly 160 cooperative and self-operated warehouses in 72 countries and 1 region, serving more than 350,000 online and offline retailers in China. | $600M / Series C / Apr 19, 2021 | |
|
|
XQIAO is a smart treadmill developer based in China. | $19.8M / Series B / Oct 16, 2018 | |
|
|
Viroad Biotechnology is a Chinese Cancer Diagnosis Firm . | Series B / Sep 14, 2018 | |
|
|
Qiandao Exploration is a leading technology-innovative commercial aerospace company. | Seed / Sep 03, 2018 | |
|
|
Beijing Mabworks Biotech, a gene engineering mAb company. Mabworks is working on ZMapp, an Ebola treatment developed by San Diego's MAPP Biopharma. It also is developing two clinical stage drug candidates: MIL60, a biosimilar to Genentech's Avastin, and MIL62, a proposed treatment for chronic lymphocytic leukemia. | $38.3M / Series B / Jan 25, 2017 | |
|
|
Hua Medicine is a clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders. Founded by pharma industry veterans and funded by a premier group of international VC investment firms such as Fidelity Asia, Fidelity Biosciences, ARCH Ventures, Venrock, SAIL and WuXiVentures, the company has in-licensed from major pharma, world-wide rights to a potential best-in-class, oral drug for the treatment of Type 2 Diabetes which utilizes a novel mechanism of action. | $50M / Series C / Apr 21, 2016 | |
|
|
Qiniu Cloud is a leading enterprise cloud service provider in China. It is committed to driving social industry development with cloud technology, and it focuses on the cloud computing industry with data intelligence and visual intelligence as its core. Through massive data and rich media scenarios across industries, Qiniu Cloud launches theintelligent video cloud integrated with CDN, object storage, cloud host, big data, content recognition platform and other product portfolios, which provides comprehensive cloud computing service for users. More than one million enterprise-level clients are using qiniu cloud to provide services for 80% of the Internet users nationwide. It provides cloud plus smart technology empowerment for users in various industries to meet the new opportunities of Artificial Intelligence and the arrival of 5G era. | $100M / Series D / Jan 25, 2016 | |
|
|
In November 2018, JD Finance was upgraded to JD Digital Technology, which consists of JD Finance, JD iCity, JD Nongmu, JD MO Media, and JD Shaodongjia.The business purpose of JD Digital Technology is to connect financial and physical industries with digital technology, help the industry to improve the level of Internet, digitization andintelligence, promote the development of the real economy and create social value.With the core technologies of data technology, AI and IoT as the core, JD Digital Technology has completed the comprehensive layout in the fields of digital finance, digital city, digital agriculture, digital marketing, digital campus, etc. In the future, JD Digital Technology will enter more real estate industries while deepening its existing business areas.Prior to rebranding, JD Finance was the financial technology arm of JD.com. It was established in 2013 to give individuals and businesses quick, easy and convenient access to the financial services they need. Leveraging JD.com ’s proprietary data resources, e-commerce expertise and industry-leading risk control systems, JD Finance offered sophisticated financial solutions in areas including financing loans, asset management, payment solutions and crowdfunding. With the JD Zhongchuang ecosystem, a holistic financial and market acceleration ecosystem, JD Finance connected early-stage enterprises with the financing and business development services they needed to grow.JD Finance had established seven major business lines: supply chain finance, consumer finance, crowdfunding, asset management, payment solutions, insurance and securities. It built up China’s leading financial technology ecosystem for enterprises and consumers and launched a range of innovative products, including Jingbaobei, Baitiao, JD Wallet, JD Finance APP, Xiaojinku, JD Microcredit and Xiaobailicai.Based on its core principle of creating long-term social value combined with its corporate values, including dedication, simplicity, perfection, synergy, innovation and user experience, JD Finance extended robust risk control capabilities and established a user-friendly customer account set up and maintenance system. By connecting financial institutions, including banks, securities firms, insurance providers, as well as JD Zhongchuang, JD Finance built a connected platform that integrates resources, reduces business costs and improves the efficiency of the industry as a whole. | Jan 18, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Harvest Global Investments invest in?
Harvest Global Investments invests primarily in Biotechnology, Medical and Information Technology startups, most often at Series B and Series C stage. Most of the 10 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Harvest Global Investments?
Public channels for Harvest Global Investments include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Harvest Global Investments?
The team at Harvest Global Investments includes Angela Wang (Vice President, Business Development), Joyce Lui (Vice President for Marketing and Business Development) and Ruiqi Wang (Executive Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!